Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study.
Vervloet MG, Boletis IN, de Francisco ALM, Kalra PA, Ketteler M, Messa P, Stauss-Grabo M, Derlet A, Walpen S, Perrin A, Ficociello LH, Rottembourg J, Wanner C, Cannata-Andía JB, Fouque D.
Vervloet MG, et al. Among authors: walpen s.
Clin Kidney J. 2021 Feb 5;14(7):1770-1779. doi: 10.1093/ckj/sfaa211. eCollection 2021 Jul.
Clin Kidney J. 2021.
PMID: 34221384
Free PMC article.